The lipase testing reagents market is expected to record a CAGR of 7% during the forecast period 2022-2032, up from US$ 590.2 Million in the year 2022 to reach a valuation of US$ 1161.01 Million by 2032.
| Report Attributes | Details |
|---|---|
| CAGR | 7 % |
| Value (2022) | US$ 590.2 Million |
| Value (2032) | US$ 1161.01 Million |
The lipase testing reagents market is anticipated to show promising growth prospects in the forecasted period 2022 to 2032.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A large number of patients suffering from acute and chronic pancreatic disorders may be leading to growth in the lipase testing reagent market. The widespread demand for lipase testing reagents because of indigestion, gastroesophageal reflux disease (GERD), and other disorders might create the fueling of the sales of lipase testing reagents as well as lipase testing reagent market for tests reagents used in lipase testing.
Disease conditions like persistent diarrhea, vitamin deficiency, and malnutrition will show the additional demand for lipase testing reagents. In children, cystic fibrosis (CF) or Shwachman-Diamond Syndrome (SDS) diagnosis may show the propelling growth of the demand for lipase testing reagents along with lipase testing reagents market.
Alternative diagnosis methods like CT scan, Endoscopy for pancreatic testing may show slower growth in the lipase testing reagents market and sales of lipase testing reagents.
Awareness of the people about cystic fibrosis and pancreatic cancer may show stagnancy in the lipase testing reagents market together with escalated demand for lipase testing reagents
Among the regions that will have a presence in the lipase testing reagents market share, North America will have the highest revenue, since people are increasingly concerned about complications related to the GIT tract.
With good hospital infrastructure and a greater number of hospitals in Europe, this region will show propelling growth for the lipase testing reagents market share together with sales of lipase testing reagents in the near future, because it has a higher number of hospitals and a better infrastructure.
Latin America region will show good demand for lipase testing reagents, due to the regional government's initiative towards the public health care program. Brazil market will be the most lucrative lipase testing reagents market for pancreatic amylase reagents.
In Asian countries like China and India, the rate of colon and rectum cancer is high due to lifestyle patterns and unhygienic conditions. This condition may show additional lipase testing reagents market share and sales of lipase testing reagents.
The Middle East and Africa are expected to account for being the least lucrative lipase testing reagents market share due to a lack of awareness about lipase test-related disorders in people.
Principal Consultant
To get a greater part of the lipase testing reagents market, players are focusing on new product launches and sophisticated technology.
Lipase Testing Reagents work on the enzymatic colour test principle. In which the colour produced after the assay method, is measured against a fixed wavelength to determine the Lipase level in serum and plasma. Lipase Testing Reagents act as important markers to study pancreas-related disorders and gall bladder cancer.
Pancreatic lipase test kits are based on the turbid metric & colorimetric methods, in which triglyceride is used as substrate. The lipase testing reagents use the colour rate assay, in which 1,2- diglyceride acts as a natural substrate. Lipase testing reagents are highly sensitive toward the natural substrate and pancreatic lipase. In the lipase testing reagents, colipase and deoxycholate were used as activators.
Examples of some of the lipase testing reagents market participants in the global lipase testing reagents market identified across the value chain include DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co.,Ltd, Randox Laboratories Ltd., Abbott, Beckman Coulter, Inc., Biocompare, Vitro Scient Co., Merck KGaA., Sisco Research Laboratories Pvt. Ltd. Biosystems S.A ,and others.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 7% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2022 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in US$ million/billion and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Indication, End-User, & Region. |
| Regional scope | North America (USA, Canada); Latin America (Mexico, Brazil); Europe (Germany, Italy, France, UK, Spain, Russia); East Asia (China, Japan, South Korea); South Asia (India, ASEAN); Oceania (Australia, New Zealand); Middle East and Africa (GCC Countries, South Africa, Northern Africa) |
| Country scope | USA, Canada, Mexico, Brazil, Germany, Italy, France, UK, Spain, Russia, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, GCC Countries, South Africa, Northern Africa |
| Key companies profiled | DIALAB GmbH; DiaSys Diagnostic Systems GmbH; Sunson Industry Group Co.;Ltd; Randox Laboratories Ltd.; Abbott; Beckman Coulter; Inc.; Biocompare; Vitro Scient Co.; Merck KGaA.; Sisco Research Laboratories Pvt. Ltd. Biosystems S.A. and others |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By Indication:
By End-User:
The lipase testing reagents market is expected to record a CAGR of 7% during the forecast period 2022-2032, up from US$590.2 Million in the year 2022 to reach a valuation of US$ 1161.01 Million by 2032.
The North America region is expected to lead the lipase testing reagents market share during forecast period.
As per the analysis, the lipase testing reagents market share is likely to be US$ 1161.01 Million by 2032.
Incidences of indigestion and gastroesophageal reflux disease (GERD) are driving growth in the lipase testing reagents market.
Explore Healthcare Insights
View Reports
Lipase Testing Reagents Market
